ArticleThe Journal of clinical investigation2017
Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma.
Lindsey N Kent et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
73 papers cite itlatest 60 shown
this paperpooled itcites it